Literature DB >> 25107427

The effect of polymeric excipients on the physical properties and performance of amorphous dispersions: Part I, free volume and glass transition.

Jinjiang Li1, Junshu Zhao, Li Tao, Jennifer Wang, Vrushali Waknis, Duohai Pan, Mario Hubert, Krishnaswamy Raghavan, Jatin Patel.   

Abstract

PURPOSE: To investigate the structural effect of polymeric excipients on the behavior of free volume of drug-polymer dispersions in relation to glass transition.
METHODS: Two drugs (indomethacin and ketoconazole) were selected to prepare amorphous dispersions with PVP, PVPVA, HPC, and HPMCAS through spray drying. The physical attributes of the dispersions were characterized using SEM and PXRD. The free volume (hole-size) of the dispersions along with drugs and polymers was measured using positron annihilation lifetime spectroscopy (PALS). Their glass transition temperatures (Tgs) were determined using DSC and DMA. FTIR spectra were recorded to identify hydrogen bonding in the dispersions.
RESULTS: The chain structural difference-flexible (PVP and PVPVA) vs. inflexible (HPC and HPMCAS)-significantly impacts the free volume and Tgs of the dispersions as well as their deviation from ideality. Relative to Tg, free volume seems to be a better measure of hydrogen bonding interaction for the dispersions of PVP, HPC, and HPMCAS. The free volume of polymers and their dispersions in general appears to be related to their conformations in solution.
CONCLUSIONS: Both the backbone chain rigidity of polymers as well as drug-polymer interaction can impact the free volume and glass transition behaviors of the dispersions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25107427     DOI: 10.1007/s11095-014-1478-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Authors:  Feng Qian; Jennifer Wang; Ruiling Hartley; Jing Tao; Raja Haddadin; Neil Mathias; Munir Hussain
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

Review 2.  Emerging trends in the stabilization of amorphous drugs.

Authors:  Riikka Laitinen; Korbinian Löbmann; Clare J Strachan; Holger Grohganz; Thomas Rades
Journal:  Int J Pharm       Date:  2012-04-28       Impact factor: 5.875

3.  Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.

Authors:  S Sotthivirat; C McKelvey; J Moser; B Rege; W Xu; D Zhang
Journal:  Int J Pharm       Date:  2013-05-04       Impact factor: 5.875

4.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.

Authors:  Hisham Al-Obaidi; M Jayne Lawrence; Sonal Shah; Henna Moghul; Noor Al-Saden; Fiza Bari
Journal:  Int J Pharm       Date:  2013-02-11       Impact factor: 5.875

Review 6.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.

Authors:  Dwayne T Friesen; Ravi Shanker; Marshall Crew; Daniel T Smithey; W J Curatolo; J A S Nightingale
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

7.  Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.

Authors:  William Curatolo; James A Nightingale; Scott M Herbig
Journal:  Pharm Res       Date:  2009-03-10       Impact factor: 4.200

8.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

9.  Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

Authors:  Hajime Konno; Tetsurou Handa; David E Alonzo; Lynne S Taylor
Journal:  Eur J Pharm Biopharm       Date:  2008-06-06       Impact factor: 5.571

10.  Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.

Authors:  Lindsay A Wegiel; Lisa J Mauer; Kevin J Edgar; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2012-11-06       Impact factor: 3.534

View more
  8 in total

Review 1.  Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations.

Authors:  Yu Luo; Yanlong Hong; Lan Shen; Fei Wu; Xiao Lin
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

2.  Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.

Authors:  Sonu Dalsania; Jagadish Sharma; Bhushan Munjal; Arvind K Bansal
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

Review 3.  Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.

Authors:  Jinjiang Li; Dhaval Patel; George Wang
Journal:  AAPS J       Date:  2016-11-28       Impact factor: 4.009

Review 4.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

5.  The Impact of Disintegrant Type, Surfactant, and API Properties on the Processability and Performance of Roller Compacted Formulations of Acetaminophen and Aspirin.

Authors:  Junshu Zhao; Otilia Koo; Duohai Pan; Yongmei Wu; Dinesh Morkhade; Sandeep Rana; Partha Saha; Arturo Marin
Journal:  AAPS J       Date:  2017-06-12       Impact factor: 4.009

6.  Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion.

Authors:  Benjamin Wu; Jinjiang Li; Yahong Wang
Journal:  AAPS J       Date:  2016-02-02       Impact factor: 4.009

7.  Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity.

Authors:  Daniel A Davis; Dave A Miller; Supawan Santitewagun; J Axel Zeitler; Yongchao Su; Robert O Williams
Journal:  Int J Pharm X       Date:  2021-07-17

8.  Mechanistic insights of the controlled release capacity of polar functional group in transdermal drug delivery system: the relationship of hydrogen bonding strength and controlled release capacity.

Authors:  Zheng Luo; Chao Liu; Peng Quan; Degong Yang; Hanqing Zhao; Xiaocao Wan; Liang Fang
Journal:  Acta Pharm Sin B       Date:  2019-11-29       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.